Common use of Authorization of Notes Clause in Contracts

Authorization of Notes. The Company will authorize the issue and sale of $100,000,000 aggregate principal amount of its 3.95% Senior Notes due July 10, 2027 (as amended, restated or otherwise modified from time to time pursuant to Section 17 and including any such notes issued in substitution therefor pursuant to Section 13, the “Notes”). The Notes shall be substantially in the form set out in Exhibit 1. Certain capitalized and other terms used in this Agreement are defined in Schedule B. References to a “Schedule” are references to a Schedule attached to this Agreement unless otherwise specified. References to a “Section” are references to a Section of this Agreement unless otherwise specified.

Authorization of Notes. The Company will authorize the issue and sale of $100,000,000 aggregate principal amount of its 3.953.86% Senior Notes due July 10June 27, 2027 2025 (as amended, restated or otherwise modified from time to time pursuant to Section 17 and including any such notes issued in substitution therefor pursuant to Section 13, the “Notes”). The Notes shall be substantially in the form set out in Exhibit Schedule 1. Certain capitalized and other terms used in this Agreement are defined in Schedule B. A. References to a “Schedule” are references to a Schedule attached to this Agreement unless otherwise specified. References to a “Section” are references to a Section of this Agreement unless otherwise specified.

Authorization of Notes. The Company will authorize the issue and sale of of: $100,000,000 aggregate principal amount of its 3.953.74% Senior Notes due July 10March 1, 2027 2022 (as amended, restated or otherwise modified from time to time pursuant to Section 17 and including any such notes issued in substitution therefor pursuant to Section 13, the “Notes”). The Notes shall be substantially in the form set out in Exhibit Schedule 1. Certain capitalized and other terms used in this Agreement are defined in Schedule B. A. References to a “Schedule” are references to a Schedule attached to this Agreement unless otherwise specified. References to a “Section” are references to a Section of this Agreement unless otherwise specified.

Authorization of Notes. The Company will authorize the issue and sale of $100,000,000 aggregate principal amount of its 3.953.75% Senior Guaranteed Notes due July 1014, 2027 2024 (the “Notes,” such term to include any such notes as amended, restated or otherwise modified from time to time pursuant to Section 17 and including any such notes issued in substitution therefor pursuant to Section 13, the “Notes”). The Notes shall be substantially in the form set out in Exhibit Schedule 1. Certain capitalized and other terms used in this Agreement are defined in Schedule B. A. References to a “Schedule” are references to a Schedule attached to this Agreement unless otherwise specified. References to a “Section” are references to a Section of this Agreement unless otherwise specified.

Authorization of Notes. The Company will authorize the issue and sale of $100,000,000 150,000,000 aggregate principal amount of its 3.953.91% Senior Notes Guaranteed Notes, Series G, due July 1030, 2027 2030 (as amended, restated or otherwise modified from time to time pursuant to Section 17 and including any such notes issued in substitution therefor pursuant to Section 13, the “Notes”). The Notes shall be substantially in the form set out in Exhibit Schedule 1. Certain capitalized and other terms used in this Agreement are defined in Schedule B. A. References to a “Schedule” are references to a Schedule attached to this Agreement unless otherwise specified. References to a “Section” are references to a Section of this Agreement unless otherwise specified.

Authorization of Notes. The Company will authorize the issue and sale of $100,000,000 aggregate principal amount of its 3.954.24% Senior Notes Guaranteed Notes, Series E, due July 10May 23, 2027 2029, (as amended, restated or otherwise modified from time to time pursuant to Section 17 and including any such notes issued in substitution therefor pursuant to Section 13, the “Notes”). The Notes shall be substantially in the form set out in Exhibit Schedule 1. Certain capitalized and other terms used in this Agreement are defined in Schedule B. A. References to a “Schedule” are references to a Schedule attached to this Agreement unless otherwise specified. References to a “Section” are references to a Section of this Agreement unless otherwise specified.

Authorization of Notes. The Company will authorize the issue and sale of $100,000,000 150,000,000 aggregate principal amount of its 3.953.12% Senior Notes Notes, due July 10April 16, 2027 2050 (as amended, restated or otherwise modified from time to time pursuant to Section 17 and including any such notes issued in substitution therefor pursuant to Section 13, the “Notes”). The Notes shall be substantially in the form set out in Exhibit Schedule 1. Certain capitalized and other terms used in this Agreement are defined in Schedule B. A. References to a “Schedule” are references to a Schedule attached to this Agreement unless otherwise specified. References to a “Section” are references to a Section of this Agreement unless otherwise specified. References to a “series” shall refer to each series of Notes or all series of Notes, as the context may require.

Authorization of Notes. The Company will authorize the issue and sale of $100,000,000 38,000,000 aggregate principal amount of its 3.951.97% Series I Senior Notes due July 10August 1, 2027 2025 (as amended, restated or otherwise modified from time to time pursuant to Section 17 and including any such notes issued in substitution therefor pursuant to Section 13, the “Notes”). The Notes shall be substantially in the form forms set out in Exhibit Schedule 1. Certain capitalized and other terms used in this Agreement are defined in Schedule B. References to a “Schedule” are references to a Schedule attached to this Agreement unless otherwise specified. References to a “Section” are references to a Section of this Agreement unless otherwise specified.

Authorization of Notes. The Company will authorize the issue and sale of $100,000,000 67,000,000 aggregate principal amount of its 3.954.61% Series J Senior Notes due July 10November 15, 2027 2028 (as amended, restated or otherwise modified from time to time pursuant to Section 17 and including any such notes issued in substitution therefor pursuant to Section 13, the “Notes”). The Notes shall be substantially in the form forms set out in Exhibit Schedule 1. Certain capitalized and other terms used in this Agreement are defined in Schedule B. A. References to a “Schedule” are references to a Schedule attached to this Agreement unless otherwise specified. References to a “Section” are references to a Section of this Agreement unless otherwise specified.

Authorization of Notes. The Company Issuer will authorize the issue and sale of $100,000,000 20,000,000 aggregate principal amount of its 3.955.80% Senior Secured Notes due July 10March 31, 2027 2023 (as amendedthe “Notes”, restated or otherwise modified from time such term to time pursuant to Section 17 and including include any such notes issued in substitution therefor pursuant to Section 13, the “Notes”). The Notes shall be substantially in the form set out in Exhibit 1. Certain capitalized and other terms used in this Agreement are defined in Schedule B. References B; and references to a “Schedule” are references or an “Exhibit” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement unless otherwise specifiedAgreement. References to a “Section” are references are, unless otherwise specified, to a Section of this Agreement unless otherwise specifiedAgreement.

Authorization of Notes. The Company will authorize the issue and sale of $100,000,000 50,000,000 aggregate principal amount of its 3.953.99% Senior Notes Guaranteed Notes, due July 107, 2027 2026 (the “Notes, such term to include any such notes as amended, restated or otherwise modified from time to time pursuant to Section 17 and including any such notes issued in substitution therefor pursuant to Section 13, the “Notes”). The Notes shall be substantially in the form set out in Exhibit Schedule 1. Certain capitalized and other terms used in this Agreement are defined in Schedule B. A. References to a “Schedule” are references to a Schedule attached to this Agreement unless otherwise specified. References to a “Section” are references to a Section of this Agreement unless otherwise specified.

Authorization of Notes. The Company will authorize the issue and sale of $100,000,000 195,000,000 aggregate principal amount of its 3.954.11% Senior Secured Notes due July 10, 2027 2030 (as amended, restated or otherwise modified from time to time pursuant to Section 17 18 and including any such notes issued in substitution therefor pursuant to Section 1314, the “Notes”). The Notes shall be substantially in the form set out in Exhibit 1. Certain capitalized and other terms used in this Agreement are defined in Schedule B. References to a “Schedule” are references or an “Exhibit” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement unless otherwise specifiedAgreement. References to a “Section” are references to a Section of to this Agreement unless otherwise specified.

Authorization of Notes. The Company will authorize the issue and sale of $100,000,000 400,000,000 aggregate principal amount of its 3.956.18% Series I Senior Notes due July 10October 4, 2027 2017 (as amendedthe “Notes”, restated or otherwise modified from time such term to time pursuant to Section 17 and including include any such notes issued in substitution therefor pursuant to Section 13, the “Notes”13 of this Agreement). The Notes shall be substantially in the form set out in Exhibit 1. Certain capitalized and other terms used in this Agreement are defined in Schedule B. References B hereto; references to a “Schedule” are references or an “Exhibit” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement unless otherwise specified. References Agreement; and references to a “Section” are are, unless otherwise specified, references to a Section of this Agreement unless otherwise specifiedAgreement.

Authorization of Notes. The Company will authorize the issue and sale of $100,000,000 75,000,000 aggregate principal amount of its 3.953.72% Senior Notes due July 10September 4, 2027 2026 (the “Notes”) as amended, restated or otherwise modified from time to time pursuant to Section 17 and including any such notes issued in substitution therefor pursuant to Section 13, the “Notes”). The Notes shall be substantially in the form set out in Exhibit Schedule 1. Certain capitalized and other terms used in this Agreement are defined in Schedule B. References to a “Schedule” are references to a Schedule attached to this Agreement unless otherwise specified. References to a “Section” are references to a Section of this Agreement unless otherwise specified.

Authorization of Notes. The Company will authorize the issue and sale of $100,000,000 150,000,000 aggregate principal amount of its 3.954.55% Senior Notes Notes, due July 10February 1, 2027 2049 (as amended, restated or otherwise modified from time to time pursuant to Section 17 and including any such notes issued in substitution therefor pursuant to Section 13, the “Notes”). The Notes shall be substantially in the form set out in Exhibit Schedule 1. Certain capitalized and other terms used in this Agreement are defined in Schedule B. A. References to a “Schedule” are references to a Schedule attached to this Agreement unless otherwise specified. References to a “Section” are references to a Section of this Agreement unless otherwise specified. References to a “series” shall refer to each series of Notes or all series of Notes, as the context may require.

Authorization of Notes. The Company will authorize the issue and sale of $100,000,000 75,000,000 aggregate principal amount of its 3.953.64% Senior Guaranteed Notes due July 10, 2027 November 30,2028 (the “Notes” as amended, restated or otherwise modified from time to time pursuant to Section 17 and including any such notes issued in substitution therefor pursuant to Section 13, the “Notes”). The Notes shall be substantially in the form set out in Exhibit Schedule 1. Certain capitalized and other terms used in this Agreement are defined in Schedule B. References to a “Schedule” are references to a Schedule attached to this Agreement unless otherwise specified. References to a “Section” are references to a Section of this Agreement unless otherwise specified.

Authorization of Notes. The Company will authorize the issue and sale of $100,000,000 180,000,000 aggregate principal amount of its 3.954.750% Senior Secured Notes due July 10, 2027 2029 (as amended, restated or otherwise modified from time to time pursuant to Section 17 and including any such notes issued in substitution therefor pursuant to Section 13, the “Notes”). The Notes shall will be issued pursuant to an Indenture substantially in the form attached hereto as Exhibit A and will be substantially in the form set out in Exhibit 1A to the Indenture. Certain capitalized and other terms used in this Agreement are defined in Schedule B. A. References to a “Schedule” are references to a Schedule attached to this Agreement unless otherwise specified. References to a “Section” are references to a Section of this Agreement unless otherwise specified.

Authorization of Notes. The Company will authorize the issue and sale of $100,000,000 aggregate principal amount of its 3.953.14% Senior Guaranteed Notes due July 10December 2, 2027 2029 (the “Notes,” such term to include any such notes as amended, restated or otherwise modified from time to time pursuant to Section 17 and including any such notes issued in substitution therefor pursuant to Section 13, the “Notes”). The Notes shall be substantially in the form set out in Exhibit Schedule 1. Certain capitalized and other terms used in this Agreement are defined in Schedule B. A. References to a “Schedule” are references to a Schedule attached to this Agreement unless otherwise specified. References to a “Section” are references to a Section of this Agreement unless otherwise specified.

Authorization of Notes. The Company will authorize the issue and sale of $100,000,000 aggregate principal amount of its 3.953.97% Senior Notes due July 10October 17, 2027 2024 (as amended, restated or otherwise modified from time to time pursuant to Section 17 and including any such notes issued in substitution therefor pursuant to Section 13, the “Notes”). The Notes shall be substantially in the form set out in Exhibit Schedule 1. Certain capitalized and other terms used in this Agreement are defined in Schedule B. A. References to a “Schedule” are references to a Schedule attached to this Agreement unless otherwise specified. References to a “Section” are references to a Section of this Agreement unless otherwise specified.

Authorization of Notes. The Company will authorize the issue and sale of $100,000,000 75,000,000 aggregate principal amount of its 3.953.92% Senior Notes due July 10, 2027 2045 (as amended, restated or otherwise modified from time to time pursuant to Section 17 and including any such notes issued in substitution therefor pursuant to Section 13, the “Notes”). The Notes shall be substantially in the form set out in Exhibit 1. A. Certain capitalized and other terms used in this Agreement are defined in Schedule B. References to a “Schedule” are references to a Schedule attached to this Agreement unless otherwise specified. References to a “Section” are references to a Section of this Agreement unless otherwise specified.

Authorization of Notes. The Company will authorize the issue and sale of $100,000,000 aggregate principal amount of its 3.953.78% Senior Notes Guaranteed Notes, Series F, due July 1019, 2027 2024, (as amended, restated or otherwise modified from time to time pursuant to Section 17 and including any such notes issued in substitution therefor pursuant to Section 13, the “Notes”). The Notes shall be substantially in the form set out in Exhibit Schedule 1. Certain capitalized and other terms used in this Agreement are defined in Schedule B. A. References to a “Schedule” are references to a Schedule attached to this Agreement unless otherwise specified. References to a “Section” are references to a Section of this Agreement unless otherwise specified.

Authorization of Notes. The Company will authorize the issue and sale of $100,000,000 175,000,000 aggregate principal amount of its 3.954.98% Senior Notes due July 10March 26, 2027 2044 (as amended, restated or otherwise modified from time to time pursuant to Section 17 and including any such notes issued in substitution therefor pursuant to Section 13, the “Notes”). The Notes shall be substantially in the form set out in Exhibit Schedule 1. Certain capitalized and other terms used in this Agreement are defined in Schedule B. A. References to a “Schedule” are references to a Schedule attached to this Agreement unless otherwise specified. References to a “Section” are references to a Section of this Agreement unless otherwise specified.

Authorization of Notes. The Company Issuer will authorize the issue and sale of $100,000,000 aggregate principal amount of its 3.954.29% Guaranteed Senior Notes due July 10August 6, 2027 2025 (as amended, restated or otherwise modified from time to time pursuant to Section 17 18 and including any such notes issued in substitution therefor pursuant to Section 1314, the “Notes”). The Notes shall be substantially in the form set out in Exhibit Schedule 1. Certain capitalized and other terms used in this Agreement are defined in Schedule B. References to a “Schedule” are references to a Schedule attached to this Agreement unless otherwise specified. References to a “Section” are references to a Section of this Agreement unless otherwise specified.

Authorization of Notes. The Company will authorize the issue and sale of $100,000,000 aggregate principal amount of its 3.954.35% Senior Notes due July 10January 30, 2027 2044 (as amended, restated or otherwise modified from time to time pursuant to Section 17 and including any such notes issued in substitution therefor pursuant to Section 13, the “Notes”). The Notes shall be substantially in the form set out in Exhibit 1. A. Certain capitalized and other terms used in this Agreement are defined in Schedule B. References to a “Schedule” are references to a Schedule attached to this Agreement unless otherwise specified. References to a “Section” are references to a Section of this Agreement unless otherwise specified.

Authorization of Notes. The Company will authorize the issue and sale of $100,000,000 20,000,000 aggregate principal amount of its 3.956.91% Senior Secured Notes due July 10January 3, 2027 2034 (as amended, restated or otherwise modified from time to time pursuant to Section 17 and including any such notes issued in substitution therefor pursuant to Section 13, the “Notes”). The Notes shall be substantially in the form set out in Exhibit Schedule 1. Certain capitalized and other terms used in this Agreement are defined in Schedule B. A. References to a “Schedule” are references to a Schedule attached to this Agreement unless otherwise specified. References to a “Section” are references to a Section of this Agreement unless otherwise specified.